We have witnessed a gratifying restoration in the UB price from early November on-ards. There are a number of reasons for this welcome circumstance. These include a reduction in the frequency iand intensity of press releases by the FDA. After all, they received their requests from Congress ("sort of) and fthere have been no further newsworthy outbreaks or recalls.
展开▼
